A volunteer receives an injection from a medical worker. REUTERS/Siphiwe Sibeko

The Food and Drug Administration’s (FDA) panel of experts questioned the safety standards of the agency’s COVID-19 vaccine approval at an advisory meeting Thursday.

Independent experts in the FDA’s vaccine advisory board said they were concerned about a vaccine being rushed out, and later proving unsafe or ineffective, per Bloomberg.

The FDA requires a two-month follow-up after a final vaccine dose before emergency approval of a vaccine. This is too short, the experts said.

“What we’re being asked to do is to build this plane as we fly it,” said Archana Chatterjee, dean of Chicago Medical School.

Visit Business

Read More At Article Source | Article Attribution